Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin.
Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin. Am J Cardiol. 2005 Jan 01; 95(1):120-2.
View in:
PubMed
subject areas
Adverse Drug Reaction Reporting Systems
Drug Therapy, Combination
Fenofibrate
Gemfibrozil
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents
Retrospective Studies
Rhabdomyolysis
United States
United States Food and Drug Administration
authors with profiles
Michael H. Davidson